SPDEF suppresses head and neck squamous cell carcinoma progression by transcriptionally activating NR4A1

Abstract

SAM pointed domain containing E26 transformation-specific transcription factor (SPDEF) plays dual roles in the initiation and development of human malignancies. However, the biological role of SPDEF in head and neck squamous cell carcinoma (HNSCC) remains unclear. In this study, the expression level of SPDEF and its correlation with the clinical parameters of patients with HNSCC were determined using TCGA-HNSC, GSE65858, and our own clinical cohorts. CCK8, colony formation, cell cycle analysis, and a xenograft tumor growth model were used to determine the molecular functions of SPDEF in HNSCC. ChIP-qPCR, dual luciferase reporter assay, and rescue experiments were conducted to explore the potential molecular mechanism of SPDEF in HNSCC. Compared with normal epithelial tissues, SPDEF was significantly downregulated in HNSCC tissues. Patients with HNSCC with low SPDEF mRNA levels exhibited poor clinical outcomes. Restoring SPDEF inhibited HNSCC cell viability and colony formation and induced G0/G1 cell cycle arrest, while silencing SPDEF promoted cell proliferation in vitro. The xenograft tumor growth model showed that tumors with SPDEF overexpression had slower growth rates, smaller volumes, and lower weights. SPDEF could directly bind to the promoter region of NR4A1 and promoted its transcription, inducing the suppression of AKT, MAPK, and NF-κB signaling pathways. Moreover, silencing NR4A1 blocked the suppressive effect of SPDEF in HNSCC cells. Here, we demonstrate that SPDEF acts as a tumor suppressor by transcriptionally activating NR4A1 in HNSCC. Our findings provide novel insights into the molecular mechanism of SPDEF in tumorigenesis and a novel potential therapeutic target for HNSCC.

References

[1] Ali J, . Genetic etiology of oral cancer. Oral Oncol., 2017, 70: 23-28.

[2] Ferlay J, . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 2010, 127: 2893-2917.

[3] Peitzsch, C., Nathansen, J., Schniewind, S. I., Schwarz, F. & Dubrovska, A. Cancer stem cells in head and neck squamous cell carcinoma: identification, characterization and clinical implications. Cancers 11, 616 (2019).

[4] Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma—an update. CA Cancer J. Clin., 2015, 65: 401-421.

[5] Shah K, Patel S, Modi B, Shah F, Rawal R. Uncovering the potential of CD44v/SYNE1/miR34a axis in salivary fluids of oral cancer patients. J. Oral. Pathol. Med., 2018, 47: 345-352.

[6] Huang GZ, Wu QQ, Zheng ZN, Shao TR, Lv XZ. Identification of candidate biomarkers and analysis of prognostic values in oral squamous cell carcinoma. Front. Oncol., 2019, 9: 1054.

[7] Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet, 2008, 371: 1695-1709.

[8] Sabherwal Y, . PDEF downregulates stathmin expression in prostate cancer. Int. J. Oncol., 2012, 40: 1889-1899.

[9] Cho JY, . Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex. J. Proteome Res., 2009, 8: 1327-1337.

[10] Oettgen P, . PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J. Biol. Chem., 2000, 275: 1216-1225.

[11] Steffan JJ, Koul HK. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor. Cancer Lett., 2011, 310: 109-117.

[12] Wu J, . SPDEF is overexpressed in gastric cancer and triggers cell proliferation by forming a positive regulation loop with FoxM1. J. Cell. Biochem., 2018, 119: 9042-9054.

[13] Zhang YQ, . CRISPR/Cas9-mediated knockout of the PDEF gene inhibits migration and invasion of human gastric cancer AGS cells. Biomed. Pharmacother., 2019, 111: 76-85.

[14] Johnson TR, . Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF. Mol. Cancer, 2010, 9

[15] Lo YH, . SPDEF induces quiescence of colorectal cancer cells by changing the transcriptional targets of β-catenin. Gastroenterology, 2017, 153: 205-218. e208

[16] Noah TK, . SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity. Gastroenterology, 2013, 144: 1012-1023.

[17] Hazel TG, Nathans D, Lau LF. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc. Natl Acad. Sci. USA, 1988, 85: 8444-8448.

[18] Ramirez-Herrick AM, Mullican SE, Sheehan AM, Conneely OM. Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice. Blood, 2011, 117: 2681-2690.

[19] Maxwell MA, Muscat GE. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl. Recept. Signal., 2006, 4: e002.

[20] Freire PR, Conneely OM. NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBPα and inflammatory signaling. Blood, 2018, 131: 1081-1093.

[21] Chen HZ, . The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling. Gut, 2012, 61: 714-724.

[22] Alexopoulou AN, . Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines. Breast Cancer Res., 2010, 12

[23] Safe S, Jin UH, Hedrick E, Reeder A, Lee SO. Minireview: role of orphan nuclear receptors in cancer and potential as drug targets. Mol. Endocrinol., 2014, 28: 157-172.

[24] Rastogi B, . Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis. Mol. Cell. Biochem., 2016, 415: 183-196.

[25] Liu PY, . Expression of Nur77 induced by an n-butylidenephthalide derivative promotes apoptosis and inhibits cell growth in oral squamous cell carcinoma. Invest N. Drugs, 2012, 30: 79-89.

[26] Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat. Rev. Immunol., 2018, 18: 309-324.

[27] Guo M, . Gene signature driving invasive mucinous adenocarcinoma of the lung. EMBO Mol. Med., 2017, 9: 462-481.

[28] Ren X, . HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma. Nat. Commun., 2017, 8

[29] AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discov. 7, 818–831 (2017).

[30] Bushweller JH. Targeting transcription factors in cancer - from undruggable to reality. Nat. Rev. Cancer, 2019, 19: 611-624.

[31] Ghadersohi A, . Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients. Int. J. Cancer, 2008, 123: 1376-1384.

[32] Wang F, Koul S, Shanmugam PST, Dong Q, Koul HK. Prostate-derived Ets factor (PDEF) inhibits metastasis by inducing epithelial/luminal phenotype in prostate cancer cells. Mol. Cancer Res., 2018, 16: 1430-1440.

[33] Buchwalter G, . PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells. Cancer Cell, 2013, 23: 753-767.

[34] Korfhagen TR, . SAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasia. Proc. Natl Acad. Sci. USA, 2012, 109: 16630-16635.

[35] Gregorieff A, . The ets-domain transcription factor Spdef promotes maturation of goblet and paneth cells in the intestinal epithelium. Gastroenterology, 2009, 137: 1333-1345. e1331-1333

[36] Pal M. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway. J. Cell Physiol., 2019, 234: 20266-20274.

[37] Cheng XH, . SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene. PLoS Genet., 2014, 10: e1004656.

[38] Thu KL, Soria-Bretones I, Mak TW, Cescon DW. Targeting the cell cycle in breast cancer: towards the next phase. Cell Cycle, 2018, 17: 1871-1885.

[39] Schaefer JS, . Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression. J. Biol. Chem., 2010, 285: 11258-11269.

[40] McMorrow JP, Murphy EP. Inflammation: a role for NR4A orphan nuclear receptors?. Biochem. Soc. Trans., 2011, 39: 688-693.

[41] Hanna RN, . NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ. Res., 2012, 110: 416-427.

[42] Murphy EP, Crean D. Molecular interactions between NR4A orphan nuclear receptors and NF-κB are required for appropriate inflammatory responses and immune cell homeostasis. Biomolecules, 2015, 5: 1302-1318.

[43] Li L, . Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation. Nat. Chem. Biol., 2015, 11: 339-346.

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81870769, 81702700)